Literature DB >> 23975313

Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?

Elizabeth Fitzsullivan1, Sara A Lari, Benjamin Smith, Abigail S Caudle, Savitri Krishnamurthy, Anthony Lucci, Elizabeth A Mittendorf, Gildy V Babiera, Dalliah M Black, Jamie L Wagner, Isabelle Bedrosian, Wendy Woodward, Sarah M Gainer, Rosa Hwang, Funda Meric-Bernstam, Kelly K Hunt, Henry M Kuerer.   

Abstract

BACKGROUND: The impact of close margins in patients with ductal carcinoma-in situ (DCIS) treated with mastectomy is unclear; however, this finding may lead to a recommendation for postmastectomy radiotherapy (PMRT). We sought to determine the incidence and consequences of close margins in patients with DCIS treated with mastectomy.
METHODS: The records of 810 patients with DCIS treated with mastectomy from 1996 through 2009 were reviewed. Clinical and pathologic factors were analyzed with respect to final margin status. Median follow-up was 6.3 years.
RESULTS: Overall, 94 patients (11.7 %) had close margins (positive, n = 5; negative but ≤1 mm, n = 54; 1.1-2.9 mm, n = 35). Independent risk factors for close margins included multicentricity, pathologic lesion size ≥1.5 cm, and necrosis, but not age, use of skin-sparing mastectomy, or immediate reconstruction (p > 0.05). Seven patients received PMRT, and none had a locoregional recurrence (LRR). Among the remaining 803 patients, the 10-year LRR rate was 1 % (5.0 % for margins ≤1 mm, 3.6 % for margins 1.1-2.9 mm, and 0.7 % for margins ≥3 mm [p < 0.001]). The 10-year rate of contralateral breast cancer was 6.4 %. On multivariate analysis, close margins was the only independent predictor of LRR (p = 0.005).
CONCLUSIONS: Close margins occur in a minority of patients undergoing mastectomy for DCIS and is the only independent risk factor for LRR. As the LRR rate in patients with close margins is low and less than the rate of contralateral breast cancer, PMRT is not warranted except for patients with multiple close/positive margins that cannot be surgically excised.

Entities:  

Mesh:

Year:  2013        PMID: 23975313      PMCID: PMC4337951          DOI: 10.1245/s10434-013-3194-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

Review 1.  Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature.

Authors:  Janet H Kim; Fattaneh Tavassoli; Bruce G Haffty
Journal:  Cancer J       Date:  2006 Mar-Apr       Impact factor: 3.360

Review 2.  Ductal carcinoma in situ of the breast.

Authors:  Harold J Burstein; Kornelia Polyak; Julia S Wong; Susan C Lester; Carolyn M Kaelin
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

3.  Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins?

Authors:  Linda W Chan; Joseph Rabban; E Shelley Hwang; Alison Bevan; Michael Alvarado; Cheryl Ewing; Laura Esserman; Barbara Fowble
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

4.  Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast.

Authors:  Grace L Smith; Benjamin D Smith; Bruce G Haffty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-05       Impact factor: 7.038

5.  Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.

Authors:  Laura A Lee; Melvin J Silverstein; Cathie T Chung; Heather Macdonald; Premal Sanghavi; Melinda Epstein; Dennis R Holmes; Howard Silberman; Wei Ye; Michael D Lagios
Journal:  Am J Surg       Date:  2006-10       Impact factor: 2.565

6.  Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.

Authors:  Arjan P Schouten van der Velden; Roel van Vugt; Jos A A M Van Dijck; Jan Willem H Leer; Theo Wobbes
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-06-04       Impact factor: 7.038

7.  Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast.

Authors:  M J Silverstein; A Barth; D N Poller; E D Gierson; W J Colburn; J R Waisman; P Gamagami
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

8.  Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.

Authors:  Stephanie K Childs; Yu-Hui Chen; Margaret M Duggan; Mehra Golshan; Stephen Pochebit; Rinaa S Punglia; Julia S Wong; Jennifer R Bellon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-11       Impact factor: 7.038

9.  Recurrence after mastectomy for ductal carcinoma in situ.

Authors:  Laura N Godat; Janet K Horton; Perry Shen; John H Stewart; Stacy Wentworth; Edward A Levine
Journal:  Am Surg       Date:  2009-07       Impact factor: 0.688

10.  Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.

Authors:  Sara A Lari; Henry M Kuerer
Journal:  J Cancer       Date:  2011-05-01       Impact factor: 4.207

View more
  11 in total

1.  Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.

Authors:  Anita Mamtani; Faina Nakhlis; Stephanie Downs-Canner; Emily C Zabor; Monica Morrow; Tari A King; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2019-08-22       Impact factor: 5.344

Review 2.  Current Therapeutic Approaches to DCIS.

Authors:  Kaleigh Doke; Shirley Butler; Melissa P Mitchell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-29       Impact factor: 2.673

3.  [Update of the German S3 breast cancer guideline : What is new for pathologists?]

Authors:  A Lebeau; C Denkert; P Sinn; M Schmidt; A Wöckel
Journal:  Pathologe       Date:  2019-03       Impact factor: 1.011

Review 4.  Ductal Carcinoma In Situ: Treatment Update and Current Trends.

Authors:  Katrina B Mitchell; Henry Kuerer
Journal:  Curr Oncol Rep       Date:  2015-11       Impact factor: 5.075

5.  Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.

Authors:  Gaiane M Rauch; Brian P Hobbs; Henry M Kuerer; Marion E Scoggins; Ana P Benveniste; Young Mi Park; Abigail S Caudle; Patricia S Fox; Benjamin D Smith; Beatriz E Adrada; Savitri Krishnamurthy; Wei T Yang
Journal:  Ann Surg Oncol       Date:  2015-09-28       Impact factor: 5.344

6.  Evolving role of skin sparing mastectomy.

Authors:  Abdul Kasem; Kefah Mokbel
Journal:  World J Clin Oncol       Date:  2014-05-10

7.  Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era.

Authors:  Anita Mamtani; Kimberly J Van Zee
Journal:  Curr Breast Cancer Rep       Date:  2020-02-24

8.  Close or positive resection margins are not associated with an increased risk of chest wall recurrence in women with DCIS treated by mastectomy: a population-based analysis.

Authors:  Jonathan Klein; Iwa Kong; Lawrence Paszat; Sharon Nofech-Mozes; Wedad Hanna; Deva Thiruchelvam; Steven A Narod; Refik Saskin; Susan J Done; Naomi Miller; Bruce Youngson; Alan Tuck; Sandip Sengupta; Leela Elavathil; Prashant A Jani; Elzbieta Slodkowska; Michel Bonin; Eileen Rakovitch
Journal:  Springerplus       Date:  2015-07-10

Review 9.  Current view on ductal carcinoma in situ and importance of the margin thresholds: A review.

Authors:  A Van Cleef; S Altintas; M Huizing; K Papadimitriou; P Van Dam; W Tjalma
Journal:  Facts Views Vis Obgyn       Date:  2014

10.  Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ.

Authors:  Simon Timbrell; Sarah Al-Himdani; Oliver Shaw; Kian Tan; Julie Morris; Nigel Bundred
Journal:  Ann Surg Oncol       Date:  2016-11-11       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.